Elenco degli articoli con argomento «dermatite atopica»
Dermatologia04 mag 2023
Efficacy and safety of abrocitinib monotherapy in adolescents and adults
Differences in atopic dermatitis (AD) disease course and manifestation with age may extend to treatment response
17 apr 2023
In Lombardia open day sulla dermatite atopica
Consulti gratuiti l'11 e il 18 marzo a Milano e Brescia
12 apr 2023
Al policlinico Federico II open day sulla dermatite atopica
Sabato 11 marzo al policlinico Federico II
31 mar 2023
Open day dermatite atopica in tutta Italia
L’11, 18 e 25 MARZO 2023 torna “Dalla parte della tua pelle”, la campagna Nazionale di sensibilizzazione sulla Dermatite Atopica dell’adulto.
14 mar 2023
Campagna nazionale di sensibilizzazione sulla Dermatite Atopica
Torna la Campagna nazionale di sensibilizzazione sulla Dermatite Atopica. L'11, il 18 e il 25 marzo consulti gratuiti.
13 mar 2023
Prima Giornata dalla parte della tua pelle
Dalla parte della tua pelle
20 feb 2023
A Review on the Safety of Using JAK Inhibitors in Dermatology
Janus kinase (JAK) inhibitors are disease-modifying agents with efficacy in treating a spectrum of burdensome dermatologic conditions
20 feb 2023
Treatment of Severe Atopic Dermatitis with Dupilumab
Atopic dermatitis is a chronic inflammatory intensively pruritic skin disease.
17 feb 2023
Dalla parte della tua pelle
Prevenzione e cura della dermatite atopica: torna la campagna nazionale di sensibilizzazione sulla dermatite atopica dell’adulto edizione 2023
30 gen 2023
Prevalence of and association between atopic dermatitis
Atopic dermatitis (AD) and food allergy (FA) share similar type 2 inflammation and commonly co-occur
13 dic 2022
Comparison of real-world treatment outcomes of systemic immunomodulating
Few data exist on differences in treatment effectiveness and safety in atopic dermatitis patients of different skin types.
07 dic 2022
Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults
Atopic dermatitis (AD) is characterized by microbial dysbiosis, immune dysregulation, and an impaired skin barrier.
31 ott 2022
Effectiveness and tolerance of Janus kinase inhibitors
Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort
31 ott 2022
Association of atopic dermatitis with new-onset migraine
Association of atopic dermatitis with new-onset migraine: A nationwide population-based cohort study
24 ott 2022
The effects of systemic immunomodulatory treatments on COVID-19
Limited data are available on the effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis (AD).
03 ott 2022
Dupilumab in children aged 6 months to younger than 6 years
Background Current systemic treatments for children younger than 6 years with moderate-to-severe atopic dermatitis
28 set 2022
Con nuove terapie più qualità vita pazienti e risparmi per SSN
Non solo prurito e bruciore della pelle a volte così intensi da impedire di concentrarsi sul lavoro o a scuola, dormire e avere rapporti sociali sereni
28 set 2022
Atopic dermatitis and risk of major neuropsychiatric disorders in children
Paediatric atopic dermatitis (AD) has been linked to neuropsychiatric comorbidities
19 set 2022
Eczema European guideline part II
The evidence- and consensus-based guideline on atopic eczema
19 set 2022
Eczema European guideline part I
The evidence-and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline